Medical Health & Life Science Research News

Chimeric antigen receptor (CAR) t-cell therapy for multiple myeloma - a pipeline analysis report scrutinized in new research

Chimeric antigen receptor (CAR) t-cell therapy for multiple myeloma - a pipeline analysis report scrutinized in new research

This report helps to analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global CAR T-cell Therapy for Multiple Myeloma market.

- Advertising -

Chimeric antigen receptor (CAR) T-cell therapy for multiple myeloma: An insight

The CAR T-Cell Therapy for Multiple Myeloma pipeline analysis report includes ongoing clinical and non-clinical trends in the global CAR T-cell therapy for multiple myeloma.

Most of the pipeline therapeutics are in early stages of development; there is no CAR T-cell therapy approved to date for multiple myeloma treatment, but other treatments are available. A long-lasting and less-frequent dose can impact the overall multiple myeloma market.

In recent past, many pilot studies and early clinical trials have shown very promising results in the treatment of multiple myeloma with CAR T-cell therapy.

- Advertising -

However, the market has yet to witness the approval of the first CAR T-cell therapy for multiple myeloma, and it may take a few years from now. The currently available treatment for multiple myeloma include chemotherapy and other drugs, bisphosphonates, radiation, surgery, stem cell transplant, and plasmapheresis.

                                                                                                                                         

Download PDF Sample of CAR T-cell Therapy for Multiple Myeloma Market [email protected] www.orbisresearch.com/contacts/request-sample/520283

 

According to the National Cancer Institute (NIH), in 2017, there will be 30,280 new cases of myeloma and an estimated 12,590 deaths occur due to this disease in the US.

Covered in this report

The report covers the present scenario and the growth prospects of the car T-cell therapy for multiple myeloma. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

CAR T-cell Therapy for Multiple Myeloma – A Pipeline Analysis Report, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects during the forecast period.

The report also includes a discussion of the key companies operating in this market.

Browse Full Report with TOC: www.orbisresearch.com/reports/inde…-analysis-report

 

Major companies

  • Juno Therapeutics
  • Kite Pharma
  • Novartis
  • Collectis

Key questions answered in this report

How will the market evolve during the forecast period?

What are the major parameters impacting the market?

What are the key market trends?

What are the challenges to market growth?

Who are the key companies in this market space?

 

Access this [email protected]  www.orbisresearch.com/contact/purchase/520283

Table of Contents
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY FOR MULTIPLE MYELOMA: AN INSIGHT

Introduction

PART 05: MAJOR REGULATORY AUTHORITIES

US

Europe

Japan

Australia

China

PART 06: PIPELINE LANDSCAPE

PART 07: COMPARATIVE ANALYSIS

Mid-stage molecules (Phase II and I/II)

Early-stage molecules (Phase I and IND)

Pre-clinical and discovery-stage molecules

PART 08: INDICATION ANALYSIS

PART 09: THERAPEUTIC ASSESSMENT BY THERAPY

Therapeutic assessment based on therapy

PART 10: THERAPEUTIC ASSESSMENT BY ROA

Therapeutic assessment based on RoA

PART 11: THERAPEUTIC ASSESSMENT BY TARGET

PART 12: KEY COMPANIES

Active companies: Category and parameters

PART 13: APPENDIX

List of abbreviations

News From

Orbis Research - Rendering Conscientious ResearchOrbis Research
Category: Market Research Publishers and RetailersCompany profile: Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have a vast database of reports from the leading publishers and authors across the gl obe. We specialize in delivering customised reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialisation. This helps our clients to map their need, and we produce the perfect requi ...